GATA3 is a transcription factor exclusively expressed by the trophectoderm. In this paper, we demonstrate that although GATA3 ablation is dispensable for trophectoderm specification and blastocyst formation in sheep, its ablation negatively affects epiblast survival during post-hatching development, making the first such observation in non-rodent mammals.
Early embryo mortality represents a major challenge in livestock production, leading to significant economic losses. However, the molecular determinants underpinning early embryo development in these species remain poorly understood. GATA3 is a key transcription factor exclusively expressed by the trophectoderm (TE) in mammalian embryos. Although its ablation does not impede trophectoderm differentiation or blastocyst formation in mice, it is lethal at later developmental stages. Here, we aimed to investigate the role of GATA3 in ovine pre- and post-hatching development in vitro as well as during conceptus elongation in vivo. By generating GATA3 knockout (KO) embryos, we confirmed that GATA3 is dispensable for TE specification and blastocyst formation in ovine. GATA3 ablation did not impact developmental rates or TE development at post-hatching stages developed in vitro but it significantly reduced epiblast survival. Following embryo transfers to evaluate the effect of GATA3 ablation at later stages, the development of extraembryonic membranes (TE and hypoblast) during conceptus elongation was unaffected by GATA3 loss. However, a significantly reduced proportion of conceptuses developed an embryonic disc after GATA3 ablation. These findings indicate that GATA3 may play a previously unrecognised role in supporting epiblast development beyond the blastocyst stage in ovine.
Reproduction is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 21 | 21 | 18 |
| PDF Downloads | 25 | 25 | 21 |
Online ISSN: 1741-7899
Print ISSN: 1470-1626
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519
